ENTRY       D11393            Mixture   Drug
NAME        Rituximab and hyaluronidase;
            Rituxan hycela (TN)
PRODUCT     RITUXAN HYCELA (Genentech)
COMPONENT   Rituximab [DR:D02994], Hyaluronidase (human recombinant) [DR:D06604]
REMARK      ATC code: L01FA01
            Product: D11393<US>
EFFICACY    Antineoplastic
  DISEASE   Follicular lymphoma [DS:H01613]
            Diffuse large B-cell lymphoma [DS:H02434]
            Chronic lymphocytic leukemia [DS:H00005]
  TYPE      Monoclonal antibody, combination
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
                L01FA CD20 (Clusters of Differentiation 20) inhibitors
                 L01FA01 Rituximab
                  D11393  Rituximab and hyaluronidase &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Monoclonal Antibody/Antibody-Drug Conjugate
               Rituximab/ Hyaluronidase
                D11393  Rituximab and hyaluronidase
DBLINKS     PubChem: 384585371
///
